Find an expert

Paul specialises in Assessment and Management of Risk and Impact of Socio-Environmental determinants on the Wellbeing of our younger generations across their life span.

His overall vision is about how we use Environmental Health Intelligence to improve decision-making towards delivering more efficient Environmental Health Practices, Services and Solutions for local and regional communities in remote and disadvantaged socio-economic settings.

Within the complex interdisciplinary domains that hold the socio-environmental determinants of wellbeing, Paul’s operational research focuses on how / what interventions would best support communities to prevent, mitigate and adapt to EH risk and impact in rapidly changing environments and climate.

Professor Janda is a NHMRC Leadership Fellow (2025-29), and serves UQ as the Director, Centre for Health Services Research, and Professor in Behavioural Science at the Faculty of Faculty of Health, Medicine & Behavioural Sciences.Professor Janda leads the NHMRC Centre for Reserch Excellence in Skin Imaging and Precision Diagnosis (2021-2025) and the NHMRC funded Synergy Roadmap Towards Melanoma Screening (2022-2026). She trained as a health psychologist and is a behavioural scientist with a research background in cancer prevention and quality of life research. Prof Janda has strong clinical collaborations, and a passion for consumer-centered digital interventions that make self-management of health-related issues easier for people. Her work focuses on applied health and clinical research problems, making a difference to cancer prevention, early detection and treatment outcomes.

Previousely, until 2017, she led the Health Determinants and Health Systems Theme at The Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT). Before her NHMRC Leadership Fellowship, research was funded through an NHMRC Translating Research into Precatice Fewllowhip (2018-2020), NHMRC Career Development Fellowship Level II (2013-2017), NHMRC Career development fellowship I (2009-12) and NHMRC early career fellowship (2004-8). She was a research fellow for the Melanoma Screening trial with the Cancer Council Queensland before joining QUT in 2006.

Amal specialises in investigating the therapeutic aspects of focused ultrasound assisted gene therapy for neurodegenerative diseases. He completed his PhD (2016-2020) at CAI/AIBN (UQ) under Prof. Kristofer Thurecht, studying the effect of different ligand densities on the distribution of nanocarriers in vitro and in vivo. He joined Prof. Terry Rabbitts’s lab at the Institute of Cancer Research London as a Postdoctoral Fellow (2020-2022), working on an intracellular antibody-assisted small molecule discovery project funded by Blood Cancer UK and by the Kay Kendall Leukemia Fund. His current research focuses on the therapeutic aspects of focused ultrasound-mediated gene therapy for neurodegenerative diseases funded by the FightMND Foundation, in collaboration with Professor Kris Thurecht, Dr. Kara Vine-Perrow, Prof. Justin Yerbury, and Prof. Anthony White at the University of Queensland and the University of Wollongong.

Clara Jiang is a postdoctoral research fellow at the Institute for Molecular Bioscience, the University of Queensland. Clara’s research focuses on using genomic and transcriptomic analysis to investigate the genetic basis of cardiovascular and psychiatric disorders, with a particular focus on female health, as well as using statistical genomic approaches to explore possible opportunities for drug repurposing. Clara graduated from the University of Queensland with Bachelor of Advanced Science (First Class Honours) in 2017, and was awarded the University Medal. Clara was awarded her PhD at the University of Queensland in 2021, where she utilised bioinformatic approaches and molecular experiments to decipher the genetic aetiology of breast cancer, specifically the regulatory role of transposons or ‘jumping genes’ in modulating the transcriptional landscape in the cancer state. Clara is also a UQ Wellness ambassador and an advocate for promoting equity, diversity and inclusion in academia.

Professor David Johnson PSM

MB BS (Hons, Univ Medal), PhD (Syd), DMed(Res), FASN, FISN, FAHMS, FRACP

Department of Kidney and Transplant Services, Division of Medicine, Building 31, Princess Alexandra Hospital

david.johnson2@health.qld.gov.au

David Johnson is full-time Director of the Metro South Kidney and Transplant Service (MSKATS) and Medical Director of the Queensland Kidney Transplant Service (QKTS) at Princess Alexandra Hospital, Professor of Medicine and Professor of Population Health at University of Queensland, and Director of the Centre for Kidney Disease Research in Brisbane, Australia. He has a number of international leadership responsibilities, including Co-Chair of the International Society of Nephrology Global Kidney Health Atlas (ISN GKHA), Co-Chair of the International Society for Peritoneal Dialysis (ISPD) Guidelines on Peritonitis Prevention and Treatment, Co-Chair of the Global PDOPPS Steering Committee, Chair of SONG-PD, Immediate Past President of the Australian and New Zealand Society of Nephrology (ANZSN), Past President of the ISPD (2018-2020), Past Councillor of the ISN (2013-2019), and member of the ISN-ACT, ISN Research and ISN Monitor groups. He is currently a chair or member of 11 national and 7 international guideline groups and is ranked by Expertscape as the “top-rated expert in dialysis in the world during the years 2013-2023.” He has influenced policy and practice through his leadership as Deputy Chair of the Australian Better Evidence And Translation in Chronic Kidney Disease (BEAT-CKD) program, Deputy Chair of the Australasian Kidney Trials Network (AKTN), Chair of the Primary Healthcare Education Advisory Committee to Kidney Health Australia (PEAK), Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Member and Past-Chair of the ANZDATA Registry Peritoneal Dialysis Working Group, and Past-Chair of the Queensland Statewide Renal Clinical Network.

Having published over 1200 original manuscripts in peer-reviewed journals and presented over 550 abstracts at national and international scientific meetings, he brings critical expertise in designing and conducting multi-centre, multi-national randomised controlled trials (RCTs), developing national and international registries, using innovative research methodologies (such as registry-based RCTs) and implementing trial findings into practice. He has held lead roles in high-impact, large, multi-centre RCTs that have informed global clinical practice, including CKD-FIX, IDEAL, balANZ, HONEYPOT, TESTING, HERO, and IMPENDIA. He is currently principal investigator of the TEACH-PD and INCH-HD trials, and chair of the PHOSPHATE Trial Global Steering Committee. He helped establish the Australian Peritonitis Registry and led the highly successful National PD Peritonitis Quality Improvement Project, which reduced national peritonitis rates by two-thirds. He also led the universal implementation of automated laboratory reporting of eGFR in ANZ which increased national detection rates by 40%.

He has won numerous awards for both his basic science and clinical research science studies, including the ANZSN TJ Neale Award for “outstanding contributions to nephrologic science” (2005), the US National Kidney Foundation International Distinguished Medal (2014), the Canadian Society of Nephrology Dimitrios Oreopoulos Award (2017) and the Asia-Pacific Society of Nephrology Priscilla Kincaid-Smith Award (2021). He was a Queensland finalist in the Australian of the Year Awards in 2009 and was awarded a Public Service Medal by the Governor-General of Australia in 2011 for outstanding public service, particularly research into the early detection and management of kidney disease.

Dr Amy Johnston currently holds a conjoint senior research fellow/senior lecturer position between University of QLD and Metro South Hospital & Health Service, Department of Emergency Medicine (based at Princess Alexandra hospital) and senior lectureship in School of Nursing, Midwifery and Social Work. For the past 4 years she worked across the academic and healthcare environments to conduct her own research as well as supporting clinicians to develop the skills and confidence to participate in, and conduct research projects relevant to their clinical work. Amy is a neurobiologist and nurse with extensive teaching and research experience and a particular interest in Emergency Department service delivery and patient flow. Her wide experience has helped her develop a broadening national and international profile. She has co-authored in excess of 90 (96) publications, 143 abstracts, between awarded approximately $0.8million in grant funding, and supported 3 PhD candidates to completion with another 5 currently working towards their PhD qualifications. Her H-index is 23 (Scopus). Field weighted citation impact 2016-2019 = 1.62 (SciVal March 2020), with 16.7% of publications in the top 10% most cited worldwide, 28.6% of publications in the top 10% of journals and 21.4% demonstrating international collaboration.

Researcher ID B-2931-2010; ORCID 0000-0002-9979-997X

A/Prof Stephen Johnston is a Reader in Reproduction (40% Teaching; 40% Research and 20% Service) in the School of Environment at the University of Queensland, where he teaches animal reproduction and captive husbandry to Bachelor of Wildlife Science and Science undergraduate and postgraduate students. He is current program coordinator for the Bachelor of Wildlife Science Program. He is also a research affiliate in the School of Veterinary Science. Stephen was trained as a zoologist and specialises in the area of reproductive biology in a broad diversity of species ranging from prawns to tigers but with a major focus on Australian mammals. A/Prof Johnston has published 300 scientific works in basic and applied science disciplines including reproductive anatomy, physiology and behaviour. He was the first person in the world to produce a pouch young following artificial insemination in a marsupial, a task that he and his colleagues have now carried out successfully in the koala, a total of 34 times. Stephen is also a specialist in the cryopreservation of marsupial spermatozoa and in the assessment of sperm DNA fragmentation, including human and domestic animal spermatozoa. A/Prof Johnston’s recent research interests and grant success include studies aimed at a better understanding of the effect of chlamydia on male koala reproduction, heat stress in koalas, sociobiology of koalas, genetic and reproductive management of koalas, wombat captive reproduction, echidna captive breeding, crocodile artificial insemination and prawn aquaculture. He is a Fellow of the Society for Reproductive Biology (2019)

Associate Professor Kelly Johnstone is a certified occupational hygienist (COH) and occupational health and safety (OHS) generalist with a focus on the protection of worker health. She is the Director of the Master of Occupational Hygiene in the School of the Environment, Faculty of Science, UQ. Kelly has experience in various industries, including education, the energy and resource sectors, construction, transport, and agriculture. She plays an active role in the Australian Institute of Health and Safety (AIHS) and the Australian Institute of Occupational Hygienists (AIOH). Kelly is currently Chair of the Rural Industry Sector Standing Committee for Workplace Health and Safety Queensland.

Kelly's research interests focus on occupational health hazards including evaluating worker exposures to pesticides, respirable crystalline silica dust, and other hazardous chemicals. She has previously worked on applied and academic projects in indoor air quality, exposure to waste anaesthetic gases, thermal risk assessment, dust characterisation, and a range of OHS management-related projects.

Operations Manager - National Biologics Facility

Deputy Director - ARC Training Centre for Biopharmaceutical Innovation

Research Areas: Discovery and engineering of antibodies for diagnostic or therapeutic uses

BScApp (Biotech) Honours Class I (1998) The University of Queensland

PhD (2008) The University of Queensland

Dr Jordan is a medically trained cancer epidemiologist who is currently Professor of Epidemiology at the School of Public Health. Before starting her PhD, she worked in rural and urban general practice for over 10 years and brings that clinical experience to her research. She is currently a NHMRC Leadership Fellow and leads projects on ovarian and thyroid cancers, examining aetiology, patterns of care and survival. Her research employs a broad range of methods including individual patient and clinician surveys, molecular epidemiology and pooling of consortia data, but she has particular expertise in large-scale data linkage.

Dr. Vaibhavi Joshi is a postdoctoral research fellow at The University of Queensland Centre for Clinical Research. She is part of the Molecular Breast Pathology Lab alongside Prof. Sunil Lakhani, A/Prof Amy McCart Reed, and A/Prof Peter Simpson. Currently, she is working with with A/Prof Peter Simpson to investigate the molecular basis of breast cancer in young women, focusing on identifying novel biomarkers and potential targets to improve outcomes for this high-risk group.

Her research explores the hallmarks of metastasis, including tumor invasion,colonisation, and the tumor microenvironment. Dr. Joshi employs advanced molecular biology techniques to study cancer progression and uncover clinically relevant targets.

Dr. Joshi welcomes students and collaborators interested in cancer biology, metastasis, and innovative therapeutic strategies to join her in exploring cutting-edge projects.

The research focuses on the evaluation and management of neck pain from a physical therapy perspective

The research in the Cervical Spine and Whiplash Research Unit in the School of Health and Rehabilitation Sciences has an applied clinical focus. Two models of neck pain are being investigated, idiopathic neck pain and neck pain following trauma. The research questions and investigates the possible physical and psychological processes underlying the pain and functional disturbances associated with neck disorders to better identify and quantify the impairments or disturbances in the sensory, muscle, sensorimotor and psychological systems.

Whiplash associated disorders

Processes associated with chronic whiplash associated disorders have been researched, identifying problems in the sensory, motor and postural control systems. A prospective study of prognostic indicators for whiplash from within 4 weeks of injury to recovery or chronicity (6 months post injury) identified sensory, motor and psychological processes associated with recovery and non recovery. A multicentre, international collaborative project is underway to test the sensitivity and specificity of these indicators. This research questions the current classification system for whiplash associated disorders. One RCT of management of chronic whiplash associated disorders has been completed. Currently an RCT is underway to test whether a pragmatic multi-professional management program for acute whiplash will lessen the incidence of transition to chronicity.

Cervicogenic headache

Research into cervicogenic headache has established the physical criteria which characterise cervicogenic headache. A specific pattern of articular and muscle impairment clearly identifies cervicogenic headache from other types of benign intermittent frequent headache with symptomatic overlap (eg tension-type headache and frequent migraine without aura). An RCT has been conducted to investigate the efficacy of physiotherapy treatment methods designed to address these impairments. Current research is investigating cervicogenic headache in the elderly.

Impairment in the neck muscle system and sensorimotor control

The nature of impairments in the cervical muscle system associated with neck pain is being researched. Impairments in the motor control of the deep and superficial neck muscles have been identified in cognitive, functional and automatic tasks. The changes appear to be generic reactions to neck pain syndromes regardless of aetiology. Two randomised controlled trials have been conducted testing the effectiveness of a specific exercise regime developed from this research. The possible physiological mechanisms underlying the effectives of different therapeutic exercise strategies are currently being researched to ensure best evidence-based practice in the field of therapeutic exercise for cervical disorders.

Dr. Aleksandr Kakinen is an NHMRC Emerging Leadership Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland. He completed his PhD in 2014 at Tallinn University of Technology, Estonia, and held a postdoctoral fellowship at Monash Institute of Pharmaceutical Sciences from 2016 to 2020.

Dr. Kakinen’s research focuses on neurodegenerative diseases, particularly amyloid-related disorders such as Parkinson’s and Alzheimer’s disease. His expertise spans structural biology, protein aggregation, neuroinflammation, and nanomedicine, with a special emphasis on developing brain-targeted delivery systems for neuroprotective therapies.

He has authored over 65 peer-reviewed publications in leading journals including Nature Communications, Advanced Science, ACS Nano, and Chemical Society Reviews. Dr. Kakinen also leads a research team that combines fundamental biophysics with translational studies to advance treatments for neurodegenerative disorders.

In addition to his scientific work, he founded a design studio specialising in scientific illustrations and biomedical animations, enhancing science communication through creative visual storytelling.

Dr Shamshad Karatela is an environmental epidemiologist and a public health researcher. From being a molecular microbiologist, she further developed her skills in public health, environmental epidemiology, exposure science, bio-monitoring, infectious diseases, microbiome and intellectual disability. She has also developed skills in program monitoring and evaluation, survey design, curricula development/training, supervision, management and data analysis. Her particular research interest focuses on understanding the long-term impacts of developmental exposures (from gestation, early life, into adolescence) to environmental chemicals/pollutants/contaminants.

Dibesh Karmacharya has a Conservation Biology degree from Wayne State College, USA and a PhD on Conservation and Microbiome Genetics from Griffith University, Australia. He worked extensively in the US for Caliper Lifesciences in New Jersey as a research scientist (transgenic animal models). He promoted Genomics and Proteomics technology platforms for GE Healthcare Lifesciences in the US and Canada. He founded the Center for Molecular Dynamics Nepal (CMDN), a wildlife genetics and clinical epidemiology research center and is the Chairman and Executive Director of the Organization. He also founded Intrepid Nepal Pvt. Ltd.-a molecular diagnostics-based Biotechnology Company, and Intrepid Cancer Diagnostics-a leading cancer diagnostic laboratory. He leads several innovative researches in Nepal including building Nepal’s first genetic database of wild tigers through Nepal Tiger Genome Project. He was the Principal Investigator of PREDICT Nepal project-an emerging pandemic threat project. He also founded BIOVAC Nepal Pvt. Ltd. - a vaccine research, development and manufacturing company. He is Wildlife Conservation Society (WCS) Regional Project Coordinator of Pandemic Prevention Leadership Initiative (PPLI). He specializes in One Health and Conservation Genetics.

Dr Kassianos is a Senior Scientist at the Conjoint Internal Medical Laboratory, Queensland Health. Dr Kassianos has made significant contributions to understanding the cell-cell communication between discrete kidney cell and immune cell populations and the therapeutic potential of targeting this cross-talk in chronic kidney disease (CKD). Dr Kassianos has been integral in the development of innovative tools for CKD analytics: (i) in situ/ex vivo profiling for integrating CKD molecular profiles with histopathology; and (ii) preclinical models for screening novel CKD therapeutics. His research is internationally recognised in the field of CKD pathobiology.

Dr Kassianos has contributed to the fields of nephrology and immunology with 41 publications, >2000 career citations (~48 citations/paper) and invited international keynote lectures. Dr Kassianos has a continued record of success in attracting competitive research funding (>$2M as CI), including an NHMRC Dora Lush Scholarship (2007-2010), an RBWH Foundation Fellowship (2012-2014) and two NHMRC Project Grants as CIA (2016-2019; 2019-2022). Dr Kassianos has publications in high-ranking specialist (nephrology, immunology) and generalist journals, including five editorial commentaries in publication issues. These include 21 publications (~50% of his papers) as first or senior author/co-author – of which, 19 (90%) are in top field-weighted journals (Q1, top 10%), including Kidney Int, J Am Soc Nephrol, Cell Death Dis and J Extracell Vesicles. During this time, Dr Kassianos has supervised 5 Early Career Researchers, 5 PhD students (3 to completion) and 2 Masters students (both to completion). Dr Kassianos is also an Editor at Frontiers in Physiology and has contributed to 3 NHMRC grant review panels (2019-2021).

Associate Professor Lauren Kearney is a registered midwife and nurse and is employed as a Conjoint Associate Professor in Midwifery between the School of Nursing, Midwifery and Social Work, UQ and the Women's and Newborn Services, Royal Brisbane and Women's Hospital. Lauren’s teaching expertise is within the postgraduate and higher degree by research areas. Her research track record is strongly focused upon maternal and child health; specifically, within the domains of evaluation of models of care (relating to the perinatal period and early years), intravenous fluid management and access during labour and birth, and facilitators to promote a positive and physiological spontaneous vaginal birth. She is also committed to enhancing women's opportunity to breastfeed and thrive in the postpartum period. Lauren has strong industry collaborations. The recipient of several competitive research grants, Lauren is passionate about improving the experience of health care for women and children through translation of high-quality evidence into practice.

Dr Shelley Keating is an Accredited Exercise Physiologist (AEP) and a Senior Lecturer in Clinical Exercise Physiology at the School of Human Movement and Nutrition Sciences, University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating leads a program of research aimed at changing the way we prioritise, access and deliver lifestyle intervention for people with obesity, non-alcoholic fatty liver disease (NAFLD)/ metabolic-associated fatty liver disease (MAFLD) and type 2 diabetes. Dr Keating holds qualifications in clinical exercise physiology BExSciRehab (Hon-1); MExSpSci (Clinical Exercise Science); PhD (Exercise Physiology) and over 15 years’ experience as an AEP developing, delivering, and disseminating exercise interventions in adults with obesity and related chronic diseases.